Wilson disease mechanisms manipulate ATP7B activity
En palabras de los autores
Copper is an essential cofactor for enzymes involved in diverse processes including mitochondrial respiration and the metabolism of neurotransmitters, collagen and melanin. However, its redox activity requires tight homeostatic control. The P-type ATPases ATP7A and ATP7B help deliver copper to cuproenzymes, and ATP7B mediates the excretion of excess copper into bile. Pathogenic ATP7B variants cause Wilson disease (WD), leading to copper accumulation in organs including the liver, kidney, and brain, and to disruption of copper-dependent processes. Current treatments primarily reduce systemic copper levels, while emerging gene therapies aim to restore ATP7B function. A complementary therapeutic strategy would be to rescue dysfunctional ATP7B using pharmacological chaperones, but their development is limited by an insufficient understanding of how WD variants perturb ATP7B structure and function. Here, we present a cryo-EM structure of human ATP7B reconstituted in lipid nanodiscs together with coarse-grained molecular dynamics simulations, as well as mutagenesis, functional and sequence analyses. We identify a salt bridge (E754-R969), crucial for the transition between inward- and outward-facing conformations, which is abolished by the R969Q disease variant. Additionally, we find a conserved stabilizing cholesterol-binding site severely disrupted by the WD variant W939C. Furthermore, we present new insights into the dynamics of metal binding domains 5 and 6 hinting at a copper relay mechanism in ATP7B. Together, these findings reveal lipid- and domain-mediated mechanisms of ATP7B regulation and explain how specific WD variants disrupt them, providing a structural framework for mutation-directed therapeutic strategies, including pharmacological chaperones.
Apareció: jueves, 19 de noviembre. bioRxiv. Preprint, todavía sin revisión por pares.